What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Susceptibility Definition in Biology and Medicine

Q: What does susceptible mean on an antibiotic report?

On an antibiotic report, susceptible means the organism is likely to be inhibited by that drug at a concentration achievable in the patient. It is based on comparing the organism's MIC to established breakpoints.

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Susceptibility Definition in Biology and Medicine

Susceptibility is the state of being likely to be affected by a harmful agent, or of being unable to resist it. In biology and medicine, the term describes a relationship between two things: a host and a threat, a pathogen and a drug, or a genome and an environmental trigger.

That relationship is always conditional. A person, a bacterial strain, or a plant is not susceptible in the abstract. It is susceptible to a specific agent, under specific conditions, at a specific dose and time. This is why the same word appears in an immunologist's note about a transplant patient, on a microbiology report about an antibiotic, and in a genetic counseling session about cancer risk. Each use points to the same underlying idea: the probability that harm occurs when exposure happens.

Understanding susceptibility matters because it drives decisions across medicine, agriculture, and public health. It decides which antibiotic is prescribed, which patients are watched most closely, which animals are bred for disease resistance, and which crops are planted. It also sits at the center of antimicrobial resistance, one of the largest threats in modern medicine.

The Core Definition and Why It Matters

The Genetics Glossary maintained by the National Human Genome Research Institute defines susceptibility simply: the state of being predisposed to, or sensitive to, developing a certain disease [1]. That definition captures two components. The first is predisposition, an underlying tendency. The second is sensitivity, a lower threshold for harm once exposure occurs.

Susceptibility is not the same as infection, disease, or death. It is a probability statement. A susceptible host may never be exposed. A susceptible bacterium may never meet the drug in question. Susceptibility describes the odds if exposure happens, not a guaranteed outcome.

The concept matters because it is actionable. If you can identify who or what is susceptible, you can intervene before harm occurs. Vaccination reduces susceptibility by training the immune system in advance. Antibiotic stewardship reduces the selective pressure that turns susceptible bacteria into resistant ones. Genetic screening identifies people whose susceptibility justifies earlier monitoring.

Susceptibility Versus Resistance, Tolerance, and Predisposition

These four terms are related but not interchangeable, and confusing them causes real errors in reasoning.

Susceptibility is the baseline state of being open to harm. It is the default condition for most organisms facing a novel threat.

Resistance is the ability to withstand a threat that would otherwise cause harm. Resistance can be innate, meaning it is built into the organism from the start, or acquired, meaning it develops after exposure or through genetic change.

Tolerance is the ability to endure a threat without being harmed while the threat is still present. A tolerant organism is not resistant in the classic sense. It may still carry the pathogen or the drug, but it suffers less damage. In microbiology, tolerance describes bacteria that survive antibiotic exposure without having a raised minimum inhibitory concentration.

Predisposition is a tendency toward a particular outcome, usually used in genetics. A predisposition raises the probability of disease but does not guarantee it. Predisposition is often the mechanism behind susceptibility.

Term	One-line definition	Example
Susceptibility	Likely to be affected or unable to resist a specific agent	An immunocompromised transplant recipient exposed to a fungal pathogen
Resistance	Able to withstand an agent that would normally cause harm	A bacterium carrying a carbapenemase gene that destroys the drug
Tolerance	Able to endure an agent without being harmed while it is present	Bacteria that survive daptomycin exposure without a raised MIC
Predisposition	A genetic or constitutional tendency toward a disease	A BRCA1 variant carrier with elevated lifetime breast cancer risk

The distinction between resistance and tolerance is subtle but consequential. A tolerant bacterium may look susceptible in a standard lab test because its MIC is unchanged, yet it survives treatment in a patient. This gap between lab results and clinical outcome is one of the most important themes in susceptibility science.

Susceptibility in Immunology: The Compromised Host

In immunology, susceptibility describes a host whose defenses are weakened, making infection more likely or more severe. The classic example is the immunocompromised patient.

Immunocompromise comes in many forms. Solid organ transplant recipients take immunosuppressive drugs to prevent rejection, which also blunt their ability to fight infections. Patients receiving chemotherapy for hematologic malignancies have depleted white blood cells. People with advanced HIV infection lose CD4 T cells. Each of these states raises susceptibility to organisms that a healthy immune system would clear easily.

The fungi in the genus Alternaria illustrate this pattern. These are dematiaceous ascomycetes, a group of dark-walled molds found widely in soil and plant material. They rarely cause disease in healthy people but can cause opportunistic infections in immunocompromised hosts [2]. A retrospective study of 41 patients found that 26 percent were solid organ transplant recipients and 15 percent had hematologic malignancies, confirming that immune status is the dominant risk factor [2].

Susceptibility in immunology is not binary. It exists on a spectrum shaped by the type and degree of immune suppression, the virulence of the organism, and the route of exposure. A patient with a mildly suppressed immune system may resist an organism that would overwhelm someone with profound neutropenia.

Host genetics also shape immunological susceptibility. Genetic variation in leukotriene A4 hydrolase (LTA4H) influences tuberculosis severity, and recent work has identified LTA4H-dependent fibroblasts at the granuloma periphery that regulate eicosanoid signaling and limit mycobacterial dissemination [3]. This shows that susceptibility to a single pathogen can be traced to specific genes and cell types, not just to broad immune status.

Susceptibility in Microbiology: MIC Breakpoints and the Meaning of "S"

In microbiology, susceptibility describes whether a microorganism can be killed or inhibited by a given antimicrobial at a concentration that can safely be achieved in a patient. This is determined by antimicrobial susceptibility testing, usually abbreviated AST.

The core measurement is the minimum inhibitory concentration, or MIC. The MIC is the lowest concentration of an antimicrobial that prevents visible growth of the organism in a standardized lab culture. The MIC is a number, typically expressed in micrograms per milliliter (µg/mL).

That number becomes clinically meaningful only when compared against a breakpoint. Breakpoints are concentration thresholds established by standards organizations such as the Clinical and Laboratory Standards Institute (CLSI) in the United States and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in Europe. An organism is categorized as susceptible (S), susceptible with increased exposure (I), or resistant (R) based on where its MIC falls relative to these thresholds.

The "I" category was redefined by EUCAST in 2019 to mean "susceptible, increased exposure." The change was intended to reduce unnecessary carbapenem prescribing by signaling that a drug could still work if the dose or exposure was optimized. A retrospective cohort study of 411 patients with wild-type Pseudomonas aeruginosa infections compared outcomes between patients treated with I-category agents and those treated with meropenem. Clinical failure rates were comparable (9.2 percent versus 6.9 percent), but meropenem use was independently associated with the emergence of carbapenem-resistant P. aeruginosa within one year (odds ratio 2.38) [4]. That finding shows how the practical meaning of susceptibility shifts with clinical context and stewardship priorities.

Different organisms require different testing approaches. For Alternaria species, posaconazole and itraconazole showed low MICs (MIC50/MIC90 of 0.06/0.5 and 0.25/0.5 µg/mL respectively), while voriconazole and isavuconazole showed higher values (1/2 and 2/4 µg/mL) [2]. These numbers tell a clinician which antifungal is more likely to work, but they do not guarantee success.

Susceptibility testing can also be predicted before results return. A temporally validated study of 423 ICU patients with Acinetobacter baumannii infection developed models to distinguish carbapenem-resistant from carbapenem-susceptible strains using routine clinical data. The XGBoost model achieved an area under the receiver operating characteristic curve of 0.878 in the test cohort, with prior carbapenem exposure and illness severity as major predictors [5]. This kind of early prediction helps clinicians choose empirical therapy while waiting for formal susceptibility results.

The genetic basis of susceptibility is increasingly well understood. In Streptococcus pneumoniae, reduced susceptibility to penicillin is mediated primarily by alterations in penicillin-binding proteins (PBPs), often alongside multidrug resistance within successful lineages [6]. In Enterococcus faecalis, lipid composition changes affect susceptibility to daptomycin, a membrane-targeting antimicrobial [7]. These mechanisms explain why susceptibility is not a fixed trait but a phenotype that can shift with genetic change, growth conditions, and prior drug exposure.

Susceptibility in Genetics: BRCA and Cancer Risk

In genetics, susceptibility describes an inherited tendency toward a disease. The term is used most often for cancer, where certain gene variants raise lifetime risk without making disease inevitable.

BRCA1 and BRCA2 are the standard examples. These genes encode proteins involved in DNA repair. People who inherit a pathogenic variant in either gene have a substantially elevated lifetime risk of breast and ovarian cancer. The variant does not cause cancer directly. It removes a layer of protection, making cells more susceptible to the accumulation of mutations that drive malignancy.

This is the essence of genetic susceptibility. It is a predisposition, not a diagnosis. Many carriers never develop cancer. Others develop it at younger ages or in multiple sites. Environmental factors, lifestyle, and other genes modify the risk.

The same logic applies across species. A review of host genes associated with infectious diseases in livestock describes how improving host genetic resistance provides a complementary approach to disease prevention by reducing susceptibility to infection and limiting pathogen spread [8]. In Pekin ducks, baseline cholesterol and LDL-C levels predicted susceptibility to DHAV-3 infection, with the highly susceptible line showing the highest levels [9]. In Bombyx mori, endogenous RNA virus-derived elements modulate susceptibility to nucleopolyhedrovirus and cypovirus, with different elements either increasing or decreasing viral accumulation [10].

These examples show that genetic susceptibility operates through diverse mechanisms. Sometimes it involves immune recognition. Sometimes it involves metabolic pathways. Sometimes it involves the structure of host receptors or the regulation of defense genes.

Context Dependence: Why In Vitro Susceptibility May Not Predict In Vivo Outcome

A bacterium that looks susceptible in a petri dish may fail to respond in a patient. This gap between laboratory results and clinical reality is one of the most important concepts in susceptibility science.

Several factors explain the gap. The first is drug exposure. A lab test uses a fixed concentration, but drug levels in a patient rise and fall with dosing, absorption, metabolism, and excretion. A drug that inhibits growth at a steady concentration in vitro may never reach that concentration at the site of infection.

The second is the site of infection. Bacteria in a biofilm, a structured community attached to a surface, behave differently from free-floating bacteria. Biofilms reduce drug penetration and create microenvironments where growth is slow and drug action is weak. A study of Staphylococcus aureus in recurrent prosthetic joint infections found that isolates were genetically diverse and susceptible at baseline, but evolved over time within the host [11].

The third is host factors. Immune status, blood flow to the infected tissue, and the presence of foreign material such as catheters or prostheses all affect whether a susceptible organism is actually cleared.

The fourth is the organism's own adaptability. Acinetobacter baumannii can amplify the crp-osmC gene cluster, which enhances growth and survival in host environments but also increases susceptibility to several antibiotics [12]. This trade-off between fitness and resistance means that susceptibility can change as the organism adapts to its niche.

The fifth is the distinction between colonization and infection. An organism may be present without causing disease. A study of vancomycin-resistant enterococci in Oman found that only 49.6 percent of isolates flagged as VRE were confirmed resistant on testing, and many represented colonization rather than active infection [13]. Treating colonization as infection leads to unnecessary antibiotic use and further resistance.

How Susceptibility Is Tested and Observed

Susceptibility is measured differently depending on the context.

In microbiology, AST is performed using standardized methods. Broth microdilution, disk diffusion, and gradient diffusion strips are common. Each method produces a result that is interpreted against CLSI or EUCAST breakpoints. Rapid phenotypic susceptibility testing is an active area of development, with the goal of shortening the time between sample collection and actionable results. A narrative review of rapid diagnostics for bloodstream infections found that the most reproducible benefits were shorter time to active therapy and earlier de-escalation when narrower therapy was safe, though effects on mortality were less consistent [14].

In immunology, susceptibility is assessed through clinical history, laboratory markers, and sometimes functional assays. CD4 counts, neutrophil counts, immunoglobulin levels, and transplant status all inform the assessment. There is no single test that captures immunological susceptibility.

In genetics, susceptibility is assessed through family history, genetic testing, and risk models. A pathogenic BRCA variant is identified by sequencing. Polygenic risk scores combine many small-effect variants into a single estimate. These tools quantify predisposition but do not predict individual outcomes.

In plant pathology, susceptibility is observed through inoculation experiments, field trials, and molecular assays. The Phytophthora infestans effector Pi22798 hijacks the host StKNOX3-StHUB1/2 complex to increase plant susceptibility by reprogramming defense gene expression [15]. The Ralstonia solanacearum effector SlXTH3 promotes lateral root development and increases susceptibility to bacterial wilt in tomato [16]. These studies show how pathogens actively manipulate host susceptibility rather than simply exploiting pre-existing weakness.

Common Mistakes and Limitations

The most common mistake is treating susceptibility as a synonym for weakness. Susceptibility is a relational property, not a character flaw. A healthy person is susceptible to a novel pathogen because they have no prior immunity. A well-defended organism can be susceptible to a specific threat that bypasses its defenses.

A second mistake is assuming that susceptibility is fixed. It changes with age, immune status, prior exposure, genetic background, and environmental conditions. A person who was resistant to a pathogen last year may be susceptible this year after immunosuppressive therapy.

A third mistake is confusing in vitro susceptibility with clinical cure. A drug that works in the lab may fail in the patient for reasons that have nothing to do with the organism's MIC.

A fourth mistake is overinterpreting genetic risk. A BRCA variant raises risk, but it does not determine outcome. Many carriers never develop cancer, and many people without the variant do.

A fifth mistake is ignoring the distinction between colonization and infection. A susceptible organism found on a swab may not be causing disease and may not require treatment.

A sixth mistake is assuming that susceptibility testing is always definitive. Breakpoints change, methods vary, and some organisms are difficult to test reliably. The "I" category exists precisely because the boundary between susceptible and resistant is not always sharp [4].

A final limitation is that susceptibility is probabilistic. It describes the likelihood of harm, not the certainty of it. This makes it useful for planning and prevention but insufficient for prediction in any single case.

Quick Review

Susceptibility is the state of being likely to be affected by a harmful agent or unable to resist it.
It is context-dependent: the same organism can be susceptible to one threat and resistant to another.
Resistance is the ability to withstand harm. Tolerance is the ability to endure it without being harmed. Predisposition is a tendency toward a disease.
In immunology, susceptibility is shaped by immune status, with transplant recipients and patients with hematologic malignancies at highest risk for opportunistic infections.
In microbiology, susceptibility is defined by MIC breakpoints, but lab results do not always predict clinical outcomes.
In genetics, susceptibility reflects inherited variants such as BRCA1 and BRCA2 that raise disease risk without causing it directly.
Susceptibility is a probability, not a destiny. It guides prevention and treatment without guaranteeing results.

Frequently Asked Questions

What is the simple definition of susceptibility?

Susceptibility is the state of being likely to be affected by a harmful agent or unable to resist it. It describes a relationship between a host and a threat, not a fixed trait of either one.

How is susceptibility different from resistance?

Resistance is the ability to withstand a threat that would otherwise cause harm. Susceptibility is the absence of that ability. A resistant organism can tolerate exposure that would harm a susceptible one.

What does susceptible mean on an antibiotic report?

On an antibiotic report, "susceptible" means the organism is likely to be inhibited by that drug at a concentration achievable in the patient. It is based on comparing the organism's MIC to established breakpoints.

Can someone be susceptible to a disease and never get it?

Yes. Susceptibility is a probability, not a guarantee. A susceptible person may never be exposed, or may be exposed and still clear the infection through other defenses.

Why does a bacterium show susceptible in the lab but fail in a patient?

Lab tests use fixed conditions that do not capture drug exposure, biofilm formation, host immunity, or the site of infection. A bacterium that looks susceptible in vitro may survive in vivo for any of these reasons.

Is genetic susceptibility the same as genetic determinism?

No. Genetic susceptibility raises the probability of disease but does not determine it. Many carriers of risk variants never develop the condition, and many people without known variants do.